A new study led by EGDRC's @mkshahmd, tests the effectiveness of the DREAM Atlanta intervention for South Asian Immigrants with #type2diabetes to improve blood pressure. View results 🔗 https://t.co/vlUy8Zd2B6
@JournalGIM over a third of patients in intervention group had controlled BP after 6 months, compared to 16.5% in usual care, 95% of patients completed the study!
Our study represents the power of collaboration, engagement, and culturally responsive design to improve outcomes for patients with DMII. Proud to build on this work through a new R01 with our NYU partners! https://t.co/bgL352IFn3 @nadiaislamnyc@EmoryFamMed@egdrc@NYU_CSAAH
Beyond thrilled to receive NoA for a new #R01 award from @NIMHD to test and scale #CHW-led telehealth models addressing co-morbid hypertension and diabetes among South Asians. This #communityengaged study builds upon our wonderful collab with @mkshahmd@NYU_CSAAH@pophealthNYC
Meet Wilhelmina Davis who has been an #Emory patient for over seven years. She was diagnosed with #gestational diabetes 33 years ago, which turned into type 2 #diabetes. Davis says because of #technology her a1c level has reduced drastically.
#DiabetesAwarenessMonth
Join @EmoryFamMed on August 1, 6 pm EST for DEI Grand Rounds: “Disparities in Patients with Limited English Proficiencies.” CME available. https://t.co/fWPCDg1F15 @EmoryHealthcare@EmoryMedicine
We are thrilled to announce Emory’s family medicine program, newly ranked this year, is 18th in U.S. News & World Report's 2023 medical specialty rankings! Learn more: https://t.co/tTlOpQTgm9 #familymedicine#FMRevolution#EmoryDifference
Exciting to see @egdrc elevated to a Woodruff Health Sciences Center - recognizes diabetes and our center’s trajectory as university-wide priorities https://t.co/3aEp9RzOEe @kmvnarayan14@GCDTR
This small pilot study was the labor of love of 10 community partners to try to create an evidence-based program designed by them and for them...https://t.co/sp9sSuJ3lZ